Andrew Goldsweig to Drug-Eluting Stents
This is a "connection" page, showing publications Andrew Goldsweig has written about Drug-Eluting Stents.
Connection Strength
0.668
-
Joseph M, Krishna MM, Ezenna C, Pereira V, Ismayl M, Nanna MG, Bangalore S, Goldsweig AM. Short Versus One-Year Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: an Updated Meta-Analysis. Am J Cardiol. 2025 Feb 15; 237:17-28.
Score: 0.228
-
Machanahalli Balakrishna A, Ismayl M, Goldsweig AM, Peters LA, Alla VM, Velagapudi P, Zhao DX, Vallabhajosyula S. Intracoronary Imaging Versus Coronary Angiography Guidance for Implantation of Second and Third Generation Drug Eluting Stents in a Systematic Review and Meta-Analysis of Randomized Controlled Trials. Am J Cardiol. 2023 09 01; 202:100-110.
Score: 0.207
-
Machanahalli Balakrishna A, Ismayl M, Walters RW, Aboeata A, Gowda RM, Vallabhajosyula S, Goldsweig AM, Dahal K. Comparing Optical Coherence Tomography and Intravascular Ultrasound Guidance for Percutaneous Coronary Intervention: Trends and Outcomes 2010-2019. Curr Probl Cardiol. 2022 Sep; 47(9):101270.
Score: 0.192
-
Xie F, Qian L, Goldsweig A, Xu D, Porter TR. Event-Free Survival Following Successful Percutaneous Intervention in Acute Myocardial Infarction Depends on Microvascular Perfusion. Circ Cardiovasc Imaging. 2020 06; 13(6):e010091.
Score: 0.042